TP53 and Marfan syndrome: Interestingly, Yamashita et al. reported that TP53 mutation/loss and RB1 loss were significantly more frequently observed in high-grade than low-grade MFS and RB1 loss was found to be a prognostic factor for adverse recurrence-free survival [45].